ZEB1 Regulates Multiple Oncogenic Components Involved in Uveal Melanoma Progression
Yao Chen(Peking University), Yongqing Liu(University of Louisville)
Cited by 58
Related Papers
Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease
|European Journal of Medicinal Chemistry|2017|307
Zeb1 links epithelial-mesenchymal transition and cellular senescence
|Development|2008|302
Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease
|European Journal of Medicinal Chemistry|2018|200
Highly Potent and Selective Butyrylcholinesterase Inhibitors for Cognitive Improvement and Neuroprotection
|Journal of Medicinal Chemistry|2021|72
Inhibition of Histone Deacetylase 6 (HDAC6) as a therapeutic strategy for Alzheimer's disease: A review (2010–2020)
|European Journal of Medicinal Chemistry|2021|69